Business Context and Reporting Period
Envoy Medical, Inc. (Nasdaq: COCH) filed a Form 8-K on December 18, 2025, reporting the entry into a material definitive agreement. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a contractual amendment regarding outstanding warrants.
Material Changes
The primary material change is the execution of Amendment No. 4 to the Common Stock Purchase Warrant on December 18, 2025. This amendment affects 1,125,499 outstanding "Shortfall Warrants" previously issued to Meteora Special Opportunity Fund I, LP and related entities (collectively, the "Meteora Parties").
- Expiration Extension: The expiration date for the Shortfall Warrants was extended from December 31, 2025, to December 31, 2026.
- Exercise Price: The exercise price remains determined by a volume-weighted average price (VWAP) formula measured weekly, subject to a minimum price of $1.50 per share.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the terms of the warrant amendment. The shares issuable upon exercise of the warrants and the resale of the warrants are registered under the Company's Form S-3 (File No. 333-276590), declared effective on August 12, 2025.
Investor Verification Checklist
- Verify the current trading price of Envoy Medical Class A Common Stock (COCH) relative to the $1.50 minimum exercise price of the Shortfall Warrants.
- Review the full text of Exhibit 10.1 (Amendment to Forward Stock Purchase Agreement) for any additional covenants or conditions not summarized in the 8-K.
- Assess the potential dilution impact of the 1,125,499 warrants if exercised at the new expiration date of December 31, 2026.
- Confirm the status of the Form S-3 registration statement (File No. 333-276590) to ensure the resale registration remains effective.